| Literature DB >> 31710486 |
Aimée Obolari Durço1, Diego Santos de Souza2, Luana Heimfarth2, Rodrigo Miguel-Dos-Santos2, Thallita Kelly Rabelo1, Tatiane de Oliveira Barreto3, Paula Rhana3, Michael Nadson Santos Santana4, Weslley Fernandes Braga3, Jader Dos Santos Cruz3, Sandra Lauton-Santos2, Valter Joviniano de Santana-Filho5, Rosana de Souza Siqueira Barreto1, Adriana Gibara Guimarães1, Jacqueline Isaura Alvarez-Leite3, Lucindo José Quintans Júnior2, Carla Maria Lins de Vasconcelos2, Márcio Roberto Viana Dos Santos2, André Sales Barreto1.
Abstract
Myocardial infarction (MI) leads to high mortality, and pharmacological or percutaneous primary interventions do not significantly inhibit ischemia/reperfusion injuries, particularly those caused by oxidative stress. Recently, research groups have evaluated several naturally occurring antioxidant compounds for possible use as therapeutic alternatives to traditional treatments. Studies have demonstrated that d-limonene (DL), a monoterpene of citrus fruits, possesses antioxidant and cardiovascular properties. Thus, this work sought to elucidate the mechanisms of protection of DL in an isoproterenol-induced murine MI model. It was observed that DL (10 μmol) attenuated 40% of the ST elevation, reduced the infarct area, prevented histological alterations, abolished completely oxidative stress damage, restored superoxide dismutase activity, and suppressed pro-apoptotic enzymes. In conclusion, the present study demonstrated that DL produces cardioprotective effects from isoproterenol-induced myocardial infarction in Swiss mice through suppression of apoptosis.Entities:
Year: 2019 PMID: 31710486 DOI: 10.1021/acs.jnatprod.9b00523
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050